Insider trading

Period: 120 months Stock: CVS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

109 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

109 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

109 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

109 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
109 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
109 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

109 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
29 Mar 2021
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated
$4.79M 62,943 at 76.15
100%
Sold half or more
26 Mar 2021
MERLO LARRY J Director
Sold, plan not stated
$20.23M 270,650 at 74.73
34.1%
26 Mar 2021
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$5.47M 73,433 at 74.49
99.1%
Sold half or more
19 Mar 2021
Moriarty Thomas M EVP & General Counsel · indirect
Sold, plan not stated
$3.65M 49,211 at 74.15
73.0%
Sold half or more
16 Mar 2021
Boratto Eva C EVP & CFO
Sold, plan not stated
$1.41M 18,882 at 74.68
21.0%
17 Feb 2021
LUDWIG EDWARD J Director
Bought
$216.00K 3,000 at 72.00
26.5%
First buy on file
19 Jan 2021
MERLO LARRY J President and CEO
Sold, plan not stated
$4.84M 62,893 at 77.00
10.7%
12 Jan 2021
Bisaccia Lisa EVP and Chief HR Officer
Sold, plan not stated
$1.94M 25,177 at 77.00
35.1%
8 Jan 2021
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$4.42M 58,896 at 75.00
56.1%
Sold half or more
8 Jan 2021
Lotvin Alan EVP and President-CVS Caremark
Sold, plan not stated
$1.94M 25,836 at 75.00
75.5%
Sold half or more
13 Nov 2020
Lotvin Alan EVP and President-CVS Caremark
Sold, plan not stated
$499.66K 7,138 at 70.00
47.1%
10 Nov 2020
Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL
Sold, plan not stated
$1.50M 21,460 at 70.00
46.2%
26 May 2020
Mayhew Jonathan E. EVP - Transformation
Sold, plan not stated
$686.14K 10,556 at 65.00
69.0%
Sold half or more
26 May 2020
Clark James David SVP, Cont & Chief Acct Officer
Sold, plan not stated
$17.55K 270 at 65.00
5.6%
11 May 2020
Lotvin Alan EVP and President-CVS Caremark
Bought
$315.68K 5,000 at 63.14
49.2%
First buy on file
28 Apr 2020
Clark James David SVP, Cont & Chief Acct Officer
Sold, plan not stated
$405.21K 6,234 at 65.00
56.4%
Sold half or more
30 Mar 2020
Clark James David SVP, Cont & Chief Acct Officer
Sold, plan not stated
$181.80K 3,030 at 60.00
23.7%
15 Jan 2020
MERLO LARRY J President and CEO
Sold, plan not stated
$19.93M 266,476 at 74.79
37.9%
8 Jan 2020
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$4.18M 57,563 at 72.63
56.1%
Sold half or more
18 Nov 2019
Lynch Karen S EVP & Pres, Aetna Bus Unit
Sold, plan not stated
$6.01M 80,143 at 75.00
65.7%
Sold half or more
4 Nov 2019
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$1.61M 23,604 at 68.00
21.9%
30 Sep 2019
Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL
Sold, plan not stated
$1.12M 17,703 at 63.00
49.0%
12 Sep 2019
Boratto Eva C EVP & CFO
Sold, plan not stated
$528.45K 8,130 at 65.00
14.7%
11 Mar 2019
BROWN C DAVID II Director
Bought
$531.80K 10,000 at 53.18
9.9%
First buy on file
11 Mar 2019
AGUIRRE FERNANDO Director
Bought
$101.82K 1,900 at 53.59
13.3%
First buy on file
8 Mar 2019
DORMAN DAVID W Director
Bought
$506.02K 9,600 at 52.71
8.5%
First buy on file
8 Mar 2019
LUDWIG EDWARD J Director
Bought
$105.60K 2,000 at 52.80
37.2%
First buy on file
1 Mar 2019
LUDWIG EDWARD J Director
Bought
$233.08K 4,000 at 58.27
290%
First buy on file
1 Mar 2019
AGUIRRE FERNANDO Director
Bought
$198.77K 3,410 at 58.29
31.3%
First buy on file
1 Mar 2019
Clark James David SVP, Cont & Chief Acct Officer
Sold, plan not stated
$96.74K 1,664 at 58.14
19.4%
1 Feb 2019
MERLO LARRY J President and CEO
Sold, plan not stated
$10.73M 166,368 at 64.51
33.5%
1 Feb 2019
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$5.01M 77,639 at 64.54
69.7%
Sold half or more
8 Jan 2019
MERLO LARRY J President and CEO
Sold, plan not stated
$11.49M 166,368 at 69.04
33.5%
29 Nov 2018
Denton David M EVP and CFO
Sold, plan not stated
$2.02M 25,159 at 80.13
98.4%
Sold half or more
14 Nov 2018
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$1.17M 14,229 at 82.00
16.8%
1 Oct 2018
Bisaccia Lisa EVP and Chief HR Officer
Sold, plan not stated 2×
$1.72M 21,534 at 80.00
50.5%
Sold half or more
1 Oct 2018
Boratto Eva C EVP, Cont & Chief Acct Officer
Sold, plan not stated
$354.08K 4,426 at 80.00
9.6%
17 Sep 2018
Boratto Eva C EVP, Cont & Chief Acct Officer
Sold, plan not stated
$1.03M 13,311 at 77.16
24.1%
27 Aug 2018
Hourican Kevin EVP & President, CVS Pharmacy
Sold, plan not stated
$642.30K 8,564 at 75.00
70.6%
Sold half or more
4 May 2018
DORMAN DAVID W Director
Bought
$1.51M 24,300 at 62.22
30.2%
First buy on file
4 May 2018
BROWN C DAVID II Director
Bought
$619.90K 10,000 at 61.99
11.0%
First buy on file
16 Feb 2018
Foulkes Helena EVP & President-CVS Pharmacy
Sold, plan not stated
$1.42M 19,965 at 71.04
30.7%
21 Dec 2017
Bisaccia Lisa EVP and Chief HR Officer
Sold, plan not stated
$2.21M 29,445 at 75.00
65.4%
Sold half or more
2 Oct 2017
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated
$1.67M 20,547 at 81.17
47.6%
18 Sep 2017
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$7.13M 85,743 at 83.14
71.7%
Sold half or more
15 Sep 2017
Foulkes Helena EVP & President-CVS Pharmacy
Sold, plan not stated
$3.22M 39,340 at 81.88
46.6%
13 Sep 2017
MERLO LARRY J President and CEO
Sold, plan not stated
$20.03M 241,150 at 83.07
44.6%
11 Sep 2017
Denton David M EVP and CFO
Sold, plan not stated 3×
$18.88M 237,078 at 79.65
86.8%
Sold half or more
11 Sep 2017
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated 2×
$7.19M 90,267 at 79.61
75.7%
Sold half or more
16 Aug 2017
SWIFT RICHARD J Director
Sold, plan not stated
$199.05K 2,500 at 79.62
43.4%
Showing 51–100 of 109. ← Newer Page 2 of 3 Older →